Drug recall · December 26, 2018
Lubrisine eye drops recall
Why: Lack of Sterility Assurance and Incorrect/Undeclared excipient: Product was found to contain undeclared colloidal silver
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%), 30 ML bottle, Manufactured and Distributed by: Results RNA, LLC, 1272 S 1380 W., Orem, UT 84058, UPC 7 9238230723 4
- Lots / codes
All Lots
- Quantity
- 10,297 bottles
- Company
- Results RNA, LLC, Orem, UT
- Distribution
- Nationwide within the United States
- Initiated
- December 14, 2018 · Voluntary: Firm initiated
- Classified
- January 14, 2019
- Reported
- December 26, 2018
- Ended
- January 29, 2021
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Propylene glycol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.